FDA LABA Orders to be Discussed at Conference Event

A press release from the International Quality and Productivity Center (IQPC) indicates that they will have presenters on the recent FDA requirements regarding Long-Acting Beta-Agonist (LABA) at their Asthma & COPD Event in Philadelphia at the end of June. Recently the FDA has ordered companies to include notices on LABA packaging that indicates the drugs should only be used with asthma controller medication.If you have questions or concerns regarding your asthma medication or use of LABAs in the treatment of asthma, contact our office to set up an appointment.